These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 21802164)

  • 1. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC
    J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES; Hunstad DA
    J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.
    Lau ME; Loughman JA; Hunstad DA
    Infect Immun; 2012 Dec; 80(12):4123-32. PubMed ID: 22966043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the NLRP3 Inflammasome Pathway by Uropathogenic
    Demirel I; Persson A; Brauner A; Särndahl E; Kruse R; Persson K
    Front Cell Infect Microbiol; 2018; 8():81. PubMed ID: 29662840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenomics of uropathogenic Escherichia coli.
    Agarwal J; Srivastava S; Singh M
    Indian J Med Microbiol; 2012; 30(2):141-9. PubMed ID: 22664427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1RA is part of the inflammasome-regulated immune response in bladder epithelial cells and influences colonization of uropathogenic E. coli.
    Lindblad A; Persson K; Demirel I
    Cytokine; 2019 Nov; 123():154772. PubMed ID: 31299415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
    Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic
    Tantibhadrasapa A; Li S; Buddhasiri S; Sukjoi C; Mongkolkarvin P; Boonpan P; Wongpalee SP; Paenkaew P; Sutheeworapong S; Nakphaichit M; Nitisinprasert S; Hsieh MH; Thiennimitr P
    Front Cell Infect Microbiol; 2024; 14():1401462. PubMed ID: 39091675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
    Madelung M; Kronborg T; Doktor TK; Struve C; Krogfelt KA; Møller-Jensen J
    BMC Microbiol; 2017 Apr; 17(1):99. PubMed ID: 28438119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.
    Schwartz DJ; Chen SL; Hultgren SJ; Seed PC
    Infect Immun; 2011 Oct; 79(10):4250-9. PubMed ID: 21807904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
    Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
    FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
    Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
    Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development.
    Goller CC; Seed PC
    Virulence; 2010; 1(4):333-7. PubMed ID: 21178466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.
    Carey AJ; Sullivan MJ; Duell BL; Crossman DK; Chattopadhyay D; Brooks AJ; Tan CK; Crowley M; Sweet MJ; Schembri MA; Ulett GC
    J Infect Dis; 2016 Feb; 213(4):659-68. PubMed ID: 26324782
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
    Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli.
    Horvath DJ; Li B; Casper T; Partida-Sanchez S; Hunstad DA; Hultgren SJ; Justice SS
    Microbes Infect; 2011 May; 13(5):426-37. PubMed ID: 21182979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.